BIOBIJOU Co.,Ltd. (KOSDAQ:489460)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,950
-550 (-4.78%)
At close: Sep 3, 2026

BIOBIJOU Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
28,55828,49129,63317,130
Revenue Growth
-16.01%-3.85%72.99%-
Gross Profit
15,96615,87914,8198,259
Operating Income
5,0044,2279,2275,165
Net Income
6,5194,1527,1883,310
Earnings Per Share
428.75298.30630.00308.13
EPS Growth
-32.20%-52.65%104.46%-

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
15,44818,69711,49013,064
Total Debt
380.69373.542,38814,849
Net Cash (Debt)
15,06818,3249,102-1,785
Net Cash Growth
-55.63%101.31%--
Net Cash Per Share
990.921316.49797.76-166.21

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
384.83-2,771558.344,073
Capital Expenditures
-316.45-348.76-97.29-35.64
Free Cash Flow
68.37-3,120461.054,038
Free Cash Flow Growth
-98.84%--88.58%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
55.91%55.73%50.01%48.21%
Operating Margin
17.52%14.84%31.14%30.15%
Pretax Margin
28.47%17.55%30.30%24.68%
Profit Margin
22.83%14.57%24.26%19.32%
FCF Margin
0.24%-10.95%1.56%23.57%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PE Ratio
26.0848.84--
PS Ratio
5.897.12--